A booster shot is an additional dose of a vaccine given after the initial series to restore protection that has faded over time. Your immune system naturally produces fewer antibodies as months and years pass after vaccination, and a booster essentially reminds it how to fight a specific infection. Boosters exist for many vaccines, not just COVID-19. Tetanus, for example, requires a booster every 10 years throughout adulthood.
How Boosters Work in Your Body
When you get your first vaccine doses, your immune system learns to recognize a pathogen and builds an army of specialized cells to fight it. Some of those cells, called memory cells, stick around long after the initial immune response fades. A booster shot reactivates those memory cells, triggering a faster and stronger response than the original series produced.
The practical result is a surge in antibodies. After a COVID-19 booster, for instance, neutralizing antibody levels rise back to or above the levels seen right after the primary series. In a study of immunocompromised patients, a third dose improved antibody responses in 80% of recipients to levels generally considered protective. Boosters also appear to extend how long those antibodies last: after two doses of an mRNA COVID-19 vaccine, antibodies have a half-life of roughly two months, meaning half the antibodies disappear in that time. After a booster, that half-life stretches to about three and a quarter months.
People who have both been vaccinated and had a natural infection (sometimes called hybrid immunity) see even more durable protection, with antibody half-lives around eight months after a boosting event. This helps explain why public health recommendations have shifted toward annual COVID-19 boosters for most healthy adults, similar to the yearly flu shot.
Booster Shot vs. Additional Primary Dose
These two terms sound interchangeable but mean different things medically. A booster dose is given to the general population after immunity from a completed vaccine series has waned over time. An additional primary dose is given to people whose immune systems didn’t mount a strong enough response to the original series in the first place, typically those who are moderately or severely immunocompromised.
The timing differs, too. During the COVID-19 rollout, immunocompromised individuals were recommended an additional primary dose just 28 days after their second mRNA shot, while boosters for the general public came at least six months after completing the primary series. The distinction matters because it reflects two different problems: one group needs more initial building blocks, while the other just needs a refresher.
Common Vaccines That Require Boosters
COVID-19 gets the most attention, but boosters are a routine part of many vaccine schedules:
- Tetanus, diphtheria, and pertussis (Tdap/Td): After the childhood series, adults need a booster every 10 years. Pregnant women receive one dose of Tdap during each pregnancy to pass protection to the newborn.
- COVID-19: For the 2024-2025 season, a single updated dose was recommended for most people aged five and older, regardless of how many previous doses they had received. Children under five who were previously unvaccinated needed a multi-dose initial series.
- Flu (influenza): Annual shots are needed because the virus mutates so quickly that last year’s vaccine no longer matches circulating strains.
Not every vaccine requires boosters. Measles, mumps, and rubella (MMR) vaccination in childhood provides long-lasting immunity for most people, with one or two doses depending on risk factors. Hepatitis A and B vaccines also tend to produce durable protection, though certain medical conditions or occupational risks may warrant additional doses.
How Effective Boosters Are
The clearest data comes from COVID-19, where researchers could track millions of people in real time. A third mRNA booster dose reduced the incidence of infection by 26% compared to the two-dose primary series alone. More importantly, it cut severe COVID-19 by 75%. Among people clinically vulnerable to severe illness, the booster was 76.6% effective at preventing severe, critical, or fatal outcomes.
That gap between infection protection and severe disease protection is worth noting. Boosters are better at keeping you out of the hospital than at preventing every mild case. This is partly because the antibodies that block infection fade relatively quickly, while the deeper layers of immune defense, including T cells that kill infected cells, tend to be more durable and kick in before illness becomes dangerous.
Side Effects to Expect
Booster side effects are similar to what you experienced with your initial vaccine doses. In a large study of COVID-19 vaccine recipients, 92.4% reported at least one side effect, with a median of three. The most common reactions were injection site pain or soreness (78.9%), fatigue (70.3%), and headache (49%). About 30% experienced muscle pain or fever, and roughly 22% had joint pain.
These reactions typically peak within 24 to 48 hours and resolve on their own within a few days. They’re signs that your immune system is responding to the vaccine, not signs of illness. Serious adverse events from boosters are rare and occur at rates comparable to the primary series.
Why Timing Matters
Getting a booster too early wastes the opportunity for your immune system to fully mature its response to the primary series. Getting one too late means you spend more time with reduced protection. The sweet spot depends on the vaccine. For COVID-19, antibodies from the primary series decline to levels that may no longer prevent infection within about six months, which is why booster intervals have generally followed that timeline. For tetanus, antibody levels decline much more gradually, making a 10-year interval sufficient.
Research on COVID-19 antibody decay suggests that even with hybrid immunity, antibodies wane to below protective levels somewhere between 6 and 12 months after the last immune event. This provides the immunological rationale for annual COVID-19 boosters in healthy adults, a schedule that has become the standard recommendation. If you’re immunocompromised, your doctor may recommend a different timeline with more frequent doses.
Updated COVID-19 Recommendations
The COVID-19 vaccine landscape has shifted significantly since the early rollout. The 2024-2025 formulation became available in August 2024, with updated recommendations for everyone aged six months and older. For most children five and older and all adults, a single updated dose was recommended regardless of how many previous COVID-19 vaccines they had received.
As of May 2025, recommendations for healthy children and adolescents aged 6 months through 17 years moved to a shared clinical decision-making model, meaning parents and healthcare providers weigh the individual benefits and risks rather than following a blanket recommendation. For pregnant or breastfeeding women, COVID-19 vaccination remains available at any point during pregnancy, with the same individualized decision-making framework. The overall trend has been toward treating COVID-19 boosters more like flu shots: a routine annual update rather than an emergency measure.